| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.08▼ | 5.01▲ | 5.00▲ | 4.62▲ | 11.65▼ |
| MA10 | 5.05▼ | 4.99▲ | 4.85▲ | 6.89▼ | 13.65▼ |
| MA20 | 5.02▼ | 4.82▲ | 4.67▲ | 11.97▼ | 13.65▼ |
| MA50 | 4.89▲ | 4.66▲ | 4.70▲ | 13.70▼ | 10.59▼ |
| MA100 | 4.68▲ | 5.39▼ | 10.65▼ | 13.66▼ | 11.23▼ |
| MA200 | 4.67▲ | 11.24▼ | 13.60▼ | 11.27▼ | 46.12▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.021▲ | 0.156▲ | -0.996▼ | -1.199▼ |
| RSI | 51.755▲ | 64.937▲ | 50.423▲ | 26.764▼ | 32.666▼ |
| STOCH | 76.822 | 79.859 | 90.023▲ | 2.555▼ | 47.997 |
| WILL %R | -81.250▼ | -19.847▲ | -14.607▲ | -94.580▼ | -94.580▼ |
| CCI | -63.768 | 74.840 | 91.174 | -57.521 | -214.960▼ |
|
Wednesday, January 14, 2026 09:28 AM
Atara Biotherapeutics (NASDAQ: ATRA) has developed Ebvallo (tabelecleucel), a novel second-line immunotherapy for Epstein–Barr virus–positive post-transplant lymphoproliferative disease (EBV-PTLD).
|
|
Monday, January 12, 2026 07:07 AM
Shares of Atara Biotherapeutics (NASDAQ:ATRA) plunged about 55% on Monday after the U.S. Food and Drug Administration delivered a Complete Response Letter declining to approve the company’s cancer ...
|
|
Monday, January 12, 2026 07:06 AM
Atara Biotherapeutics stock drops on FDA rejection of EBVALLO BLA for serious post-transplant complication. FDA raises new concerns.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/01/26 | 4.56 | 5.14 | 4.56 | 5.01 | 549,563 |
| 21/01/26 | 4.34 | 4.69 | 4.20 | 4.60 | 418,221 |
| 20/01/26 | 4.49 | 4.79 | 4.25 | 4.32 | 597,060 |
| 16/01/26 | 4.70 | 5.0028 | 4.52 | 4.54 | 506,263 |
| 15/01/26 | 4.48 | 5.19 | 4.40 | 4.62 | 1,094,213 |
| 14/01/26 | 4.50 | 4.82 | 4.36 | 4.47 | 870,200 |
| 13/01/26 | 5.96 | 5.96 | 4.2518 | 4.37 | 2,488,359 |
| 12/01/26 | 5.62 | 6.51 | 5.58 | 5.88 | 4,617,000 |
| 09/01/26 | 17.68 | 17.98 | 13.08 | 13.67 | 843,100 |
| 08/01/26 | 15.10 | 17.97 | 14.90 | 17.44 | 416,200 |
|
|
||||
|
|
||||
|
|